top of page
We invite you to view recent scientific poster presentation data. The posters are categorized by disease state. Click on the disease state below to view all posters in that category.
Search by
Poster
Number
1, 2, 3, 4,
5, 6, 7, 8,
9, 10, 11, 12,
13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66
Psoriasis
Poster 50
Treatment of Plaque Psoriasis Involving High-Impact Sites with Icotrokinra, a Targeted Oral Peptide: Pooled Analyses of 4 Phase 3 Placebo-Controlled Trials Jennifer Soung, April W. Armstrong, Ronald B. Vender, Josep Riera-Monroig, Michael Sebastian, Ofelia Reyes-Servin, Bassey Effiom Edem, Ming-Chun Hsu, Shu Li, Ya-Wen Yang, Linda Stein Gold < PREVIOUS POSTER NEXT POSTER > POSTER 50
Poster 52
Inefficiencies of Off-Label Therapy in the Prevention of Generalized Pustular Psoriasis (GPP) Flares: Real-World Evidence from Europe Laurent Misery, Denis Jullien, Manuelle Viguier, Richard B. Warren, Christopher E.M. Griffiths, Michael Sticherling, Bhargav Lakshminarasimhan, Nichiren Pillai, Shah Alam Khan, Elke M.G.J. de Jong, Anna Balato, Stefano Piaserico < PREVIOUS POSTER NEXT POSTER > POSTER 52
Poster 53
The Burden and Management of Flares Among Pregnant Patients with Generalized Pustular Psoriasis (GPP): Real-Worlda Evidence (RWE) from the Global SCRIPTOR Study Laurent Misery, Denis Jullien, Manuelle Viguier, Richard B. Warren, Christopher Griffiths, Latha R. Selvarajah, Azura Mohd Affandi6 Renata Magalhães, Anber Tanaka, Slaheddine Marrakchi, Wen-Hung Chung, Tsen-Fang Tsai, Bhargav Lakshminarasimhan, Nichiren Pillai, Shah Alam Khan, Rafael Sani Simoes, Mark G. Lebwohl, Xing
Poster 54
Characterization of Generalized Pustular Psoriasis (GPP) Severity via Individual GPP Physician Global Assessment (GPPGA) Components During a Non-Flaring Period: Baseline Data from EFFISAYIL 2 Arash Mostaghimi, Milan J. Anadkat, James G. Krueger, Akimichi Morita, Joseph F. Merola, Jason Guercio, Ming Tang, Christian Thoma, Mark G. Lebwohl < PREVIOUS POSTER NEXT POSTER > POSTER 54
Poster 55
Generalized Pustular Psoriasis: A Systematic Literature Review of Mortality and Comorbidity Data Mark Lebwohl, Bruce Strober, Siew Eng Choon, Lluís Puig, Richard Warren, Akimichi Morita, Nichiren Pillai, Bhargav Lakshminarasimhan, Shah Alam Khan, Rafael Sani Simoes, Min Zheng < PREVIOUS POSTER NEXT POSTER > POSTER 55
Poster 56
Efficacy and Safety of Brodalumab in High BMI Participants With Moderate-to-Severe Plaque Psoriasis: The Patient Journey Mark G. Lebwohl, MD; Eingun James Song, MD, FAAD; Tina Bhutani, MD, MAS, FAADC; Wilson Liao, MD; April W. Armstrong, MD, MPH < PREVIOUS POSTER NEXT POSTER > POSTER 56
Poster 57
Once-Daily Oral Zasocitinib Demonstrates Rapid and Reproducible Skin Clearance with a Consistent Safety Profile in Moderate-to-Severe Plaque Psoriasis: Results from Two Randomized Phase 3 Trials (LATITUDE-PsO-3001 and 3002) Melinda Gooderham, Vivian Laquer, Jianzhong Zhang, Joanna Narbutt, Akimichi Morita, Paula Luna, Wenwen Zhang, Warren Winkelman, Edith Angellotti, Kim Papp, April Armstrong < PREVIOUS POSTER NEXT POSTER > POSTER 57
Poster 58
Bimekizumab On-Treatment Remission as Defined by the National Psoriasis Foundation: 1-Year Results versus Ustekinumab and Secukinumab in Patients with Moderate-to-Severe Plaque Psoriasis April Armstrong, Lourdes Pérez-Chada, Mark Lebwohl, Deepak M.W. Balak, George M. Lewitt, Richard B. Warren, Richard G. Langley, Diamant Thaçi, George Han, Heather Herr, Balint Szilagyi, Sarah Kavanagh, Andrew Blauvelt < PREVIOUS POSTER NEXT POSTER > POSTER 58
bottom of page